US SB288 | 2021-2022 | 117th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on February 8 2021 - 25% progression, died in committee
Action: 2021-02-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

TRANSPLANT Act of 2021 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021

Sponsors


History

DateChamberAction
2021-02-08SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)

Same As/Similar To

HB941 (Same As) 2021-05-26 - Became Public Law No: 117-15.

Subjects


US Congress State Sources


Bill Comments

feedback